Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

$FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma$

FDA approves selinexor for relapsed/refractory diffuse large B-cell lymphoma

Cancer drug cures COVID-19 patient with acute respiratory distress

Cancer drug cures COVID-19 patient with acute respiratory distress

AACR 2020: Personalised cancer vaccine plus atezolizumab shows clinical activity in patients with advanced solid tumours

AACR 2020: Personalised cancer vaccine plus atezolizumab shows clinical activity in patients with advanced solid...

How cancer drugs find their targets could lead to a new toolset for drug development

How cancer drugs find their targets could lead to a new toolset for drug development

Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer

Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer

FDA grants accelerated approval to lurbinectedin for metastatic small cell lung cancer

FDA grants accelerated approval to lurbinectedin for metastatic small cell lung cancer

FDA approves gemtuzumab ozogamicin for CD33-positive AML in paediatric patients

FDA approves gemtuzumab ozogamicin for CD33-positive AML in paediatric patients

Researchers generate developmental map of human T-cells

Researchers generate developmental map of human T-cells

Drug with new approach on impeding DNA repair shows promise in first clinical trial

Drug with new approach on impeding DNA repair shows promise in first clinical trial

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies

More from ecancer